SEC Form 4 · accession 0001509432-15-000013
RPX Corp · RPXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Amster
Officer — Chief Executive Officer · Director
Period of report
Feb 2, 2015
Accepted (ET)
Feb 4, 2015 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509432
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Feb 2, 2015 | S | 10,444 | $12.3879 | D | 979,187 | I | By Trust |
| Common StockF4,F5 | Feb 2, 2015 | S | 8,356 | $12.3897 | D | 307,520 | I | See Footnote |
| Common StockF6,F3 | Feb 3, 2015 | S | 10,389 | $12.6842 | D | 968,798 | I | By Trust |
| Common StockF7,F5 | Feb 3, 2015 | S | 8,311 | $12.6809 | D | 299,209 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported was effected pursuant to a 10b5-1 trading plan adopted by the Trustees of The John & Colleen Amster Living Trust dated 3/2/2000 and JCA LLC on February 28, 2014.
- F2The price reported in column 4 is the weighted average price. The shares were sold in multiple transactions ranging from $12.24 to $12.535, inclusive. The reporting person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6) and (7) to this Form 4.
- F3Shares held by John A. Amster and Colleen Q. Amster, Trustees of The John & Colleen Amster Living Trust dated 3/2/2000.
- F4The price reported in column 4 is the weighted average price. The shares were sold in multiple transactions ranging from $12.24 to $12.54, inclusive.
- F5Shares held by JCA, LLC.
- F6The price reported in column 4 is the weighted average price. The shares were sold in multiple transactions ranging from $12.54 to $12.87, inclusive.
- F7The price reported in column 4 is the weighted average price. The shares were sold in multiple transactions ranging from $12.53 to $12.83, inclusive.